Diversify Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Diversify Advisory Services's VRTX Position: Q2 2026 in Review
Diversify Advisory Services increased its Vertex Pharmaceuticals (VRTX) stake by 2,160% in Q2 2026, buying an estimated $9.39M and bringing the position to 22,168 shares worth $10.6M. The position accounts for 0.18% of the portfolio, ranked #125.
Diversify Advisory Services first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Diversify Advisory Services held 22,168 shares of Vertex Pharmaceuticals worth $10.6M as of Q2 2026.
- Diversify Advisory Services bought 21,187 Vertex Pharmaceuticals shares in Q2 2026, an estimated $9.39M.
- Vertex Pharmaceuticals made up 0.18% of Diversify Advisory Services's portfolio in Q2 2026, its #125 holding.
- Diversify Advisory Services first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.